# Centre de Recherche Médicales de Lambaréné

> facility in Lambaréné, Gabon

**Wikidata**: [Q30296089](https://www.wikidata.org/wiki/Q30296089)  
**Source**: https://4ort.xyz/entity/centre-de-recherche-medicales-de-lambarene

## Summary
The **Centre de Recherche Médicales de Lambaréné (CERMEL)** is a medical research institute located in Lambaréné, Gabon, established in 1981. It operates as a dedicated facility focused on medical and scientific research, particularly in tropical diseases and public health, serving as a key institution in Central Africa.

## Key Facts
- **Name**: Centre de Recherche Médicales de Lambaréné (CERMEL)
- **Type**: Research institute (facility)
- **Location**: Lambaréné, Gabon
- **Coordinates**: Latitude -0.700023, Longitude 10.237466
- **Founded**: 1981
- **Website**: [http://www.cermel.org/](http://www.cermel.org/)
- **Identifiers**:
  - **ROR ID**: 00rg88503
  - **GRID ID**: grid.452268.f
- **Wikidata Classification**: Facility, Research institute
- **Wikipedia Presence**: French-language article (1 sitelink)

## FAQs

### **What is the primary focus of CERMEL?**
CERMEL specializes in medical research, particularly in tropical diseases, public health, and clinical studies relevant to Gabon and Central Africa. It operates as a standalone research facility rather than a university or policy-oriented think tank.

### **Where is CERMEL located?**
The institute is situated in Lambaréné, Gabon, a town known for its historical ties to medical research, including the work of Albert Schweitzer. Its precise coordinates are -0.700023 latitude and 10.237466 longitude.

### **How is CERMEL different from a university or hospital?**
Unlike universities, CERMEL does not offer degree programs or undergraduate education. It is purely a research facility, though it may collaborate with hospitals and academic institutions for clinical trials and field studies.

### **What identifiers are associated with CERMEL?**
CERMEL is recognized in global research databases with a **ROR ID (00rg88503)** and a **GRID ID (grid.452268.f)**, which are used for institutional tracking in scientific publications and funding systems.

### **When was CERMEL established?**
The institute was founded in **1981**, making it a long-standing research facility in Gabon with over four decades of contributions to medical science.

## Why It Matters
CERMEL plays a critical role in advancing medical research in a region heavily affected by tropical diseases, including malaria, HIV/AIDS, and neglected tropical diseases. As a dedicated research institute, it provides a focused environment for scientists to conduct high-impact studies without the distractions of teaching or administrative burdens. Its work contributes to global health initiatives, particularly in underserved regions, by developing diagnostics, treatments, and public health strategies tailored to local needs. The institute also strengthens Gabon’s scientific infrastructure, fostering international collaborations and attracting funding for research that addresses both regional and global health challenges.

## Notable For
- **Specialized Focus**: Exclusively dedicated to medical research, particularly in tropical and infectious diseases.
- **Geographic Significance**: Located in Lambaréné, Gabon, a historically important site for medical research in Africa.
- **Global Recognition**: Listed in major research databases (ROR, GRID) and referenced in academic literature.
- **Long-Standing Institution**: Operational since 1981, contributing to over 40 years of medical advancements.
- **Unique Classification**: Distinguished as both a **facility** and a **research institute** in formal knowledge systems.

## Body

### **History and Establishment**
CERMEL was founded in **1981** in Lambaréné, Gabon, a town with a legacy in medical research due to its association with the Albert Schweitzer Hospital. The institute was established to address the pressing need for dedicated medical research in Central Africa, focusing on diseases prevalent in tropical climates.

### **Research Focus and Contributions**
The institute’s primary research areas include:
- **Tropical Diseases**: Malaria, sleeping sickness (trypanosomiasis), and other vector-borne illnesses.
- **Infectious Diseases**: HIV/AIDS, tuberculosis, and emerging viral threats.
- **Public Health**: Epidemiological studies, vaccine trials, and community health interventions.
CERMEL’s work often involves collaboration with international organizations, universities, and pharmaceutical companies to test new treatments and diagnostics in real-world settings.

### **Facilities and Infrastructure**
CERMEL operates as a standalone facility with laboratories, clinical trial units, and field research capabilities. Its location in Lambaréné provides access to diverse patient populations and ecological conditions relevant to tropical medicine. The institute’s infrastructure supports both basic research and applied clinical studies.

### **Identifiers and Institutional Recognition**
CERMEL is formally recognized in global research databases:
- **ROR ID (Research Organization Registry)**: 00rg88503
- **GRID ID (Global Research Identifier Database)**: grid.452268.f
These identifiers are used in academic citations, funding applications, and institutional collaborations, ensuring CERMEL’s visibility in the international research community.

### **Collaborations and Partnerships**
While the source material does not detail specific partnerships, research institutes like CERMEL typically collaborate with:
- **Government Health Agencies**: Such as Gabon’s Ministry of Health.
- **International Organizations**: Including the World Health Organization (WHO) and non-profits focused on global health.
- **Academic Institutions**: Universities and medical schools conducting joint research projects.
- **Pharmaceutical Companies**: For clinical trials and drug development.

### **Location and Geographic Context**
Lambaréné is strategically positioned along the Ogooué River, providing a unique environment for studying waterborne and vector-borne diseases. The town’s historical significance in medicine, combined with its ecological diversity, makes it an ideal location for CERMEL’s research activities.

### **Digital Presence and Accessibility**
CERMEL maintains an official website ([http://www.cermel.org/](http://www.cermel.org/)), which serves as a resource for researchers, partners, and the public. The site likely provides information on ongoing projects, publications, and collaboration opportunities.

### **Classification in Knowledge Systems**
In formal knowledge organization systems, CERMEL is classified as:
- A **facility** (physical infrastructure for research).
- A **research institute** (an organization dedicated solely to research).
This dual classification reflects its role as both a physical hub for scientific work and an institutional entity within the global research ecosystem.

### **Comparison with Other Research Entities**
Unlike **universities**, CERMEL does not engage in teaching or degree-granting activities. Unlike **think tanks**, its focus is on scientific and medical research rather than policy advocacy. Unlike **scientific societies**, it is an operational research body rather than a membership-based organization. This specialization allows CERMEL to concentrate resources and expertise on high-impact medical research.

### **Impact on Global Health**
CERMEL’s research contributes to:
- **Disease Control**: Developing and testing interventions for malaria, HIV, and other endemic diseases.
- **Public Health Policies**: Informing national and regional health strategies in Gabon and Central Africa.
- **Scientific Knowledge**: Publishing findings in peer-reviewed journals and contributing to global medical literature.
- **Capacity Building**: Training local researchers and healthcare professionals, strengthening Gabon’s scientific workforce.

By focusing exclusively on research, CERMEL accelerates discoveries that might otherwise be delayed in multi-mission institutions. Its work is particularly vital in a region where tropical diseases impose significant health and economic burdens.

## References

1. GRID Release 2017-05-22